Local News: Demorest, GA 

 | 

Sign Up

 | 

Sign In

Advertisment

Hypogonadism Wire

Comprehensive News Feed for Hypogonadism.

Results 1 - 2 of 2 in Hypogonadism

  1. FDA taking more time to review Endo drug

    Aug 31, 2009 | Philadelphia Business Journal

    Endo Pharmaceuticals said Wednesday it was informed by the Food and Drug Administration that the agency has extended by three months its review of the company's new drug application for a hypogonadism treatment.

    Comment?

    Related Topix: Biotech, Medicine, Endo Pharmaceuticals Holdings, Healthcare Industry, Food and Drug Administration, Health

  2. FDA Extends Review of Endo's Testosterone Drug Candidate by 3 MonthsRead the original story

    Sep 2, 2009 | Pharmaceutical Processing

    ... for more data about the drug. The drug is a long-acting testosterone undecanoate injection intended to treat hypogonadism, which is a hormonal condition that interferes with the functioning of the testes. The injection is sold outside the U.S. as ...

    Comment?

    Related Topix: Biotech, Medicine, Endo Pharmaceuticals Holdings, Healthcare Industry, Health